Skip to main content

Advertisement

SpringerLink
Log in

Association of a multidrug resistance 1 gene polymorphism and colorectal cancer in the Korean population

  • Research Article
  • Published:
Oriental Pharmacy and Experimental Medicine Aims and scope Submit manuscript

Abstract

Multi-drug resistance 1 (MDR1) gene encodes P-glycoprotein, which is a transmembrane transporter that acts as an energy-dependent efflux pump of xenobiotics and various chemotherapeutic drugs. To investigate relationships between C3435T (exon 26) and G2677T/A (exon 21) polymorphisms of MDR1 and gastric cancer (GC) or colorectal cancer (CRC), 102 GC patients, 193 CRC patients, and 200 healthy subjects were genotyped by pyrosequencing analysis. The genotype frequencies of 2677T/A and A/A of MDR1 in CRC patients (5.7 %, 1.6 %, respectively) were significantly lower than controls (12.5 %, 5.0 %, respectively) (P < 0.05). There was no significant difference in the MDR1 genotype frequencies between GC patients and controls. Our findings suggest that the G2677T/A polymorphism of MDR1 is significantly associated with risk of CRC in the Korean population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Balcerczak E, Panczyk M, Piaskowski S et al (2010) ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer. Int J Colorectal Dis 25:1167–1176

    Article  PubMed  Google Scholar 

  • Cascorbi I, Gerloff T, Johne A et al. (2001) Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 69:169–174

    Google Scholar 

  • Cordon-Cardo C, O'Brien JP, Casals D et al (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites. Proc Natl Acad Sci U S A 86:695–698

    Article  PubMed  CAS  Google Scholar 

  • Ding L, Chen XP, Zhang ZW et al (2005) Synergistic effect of bromocriptine and tumor necrosis factor-alpha on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm. World J Gastroenterol 28:5621–5626

    Google Scholar 

  • Drescher S, Schaeffeler E, Hitzl M et al (2002) MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br J Clin Pharmacol 53:526–534

    Article  PubMed  CAS  Google Scholar 

  • Fojo AT, Ueda K, Slamon DJ et al (1987) Expression of a multidrug-resistance gene in human tumors and tissue. Proc Natl Acad Sci U S A 84:265–269

    Article  PubMed  CAS  Google Scholar 

  • Gaikovitch E, Mrozikievicz P, Wagner F et al (2004) Association of C3435T and G2677T/A polymorphisms of multidrug resistance gene with colorectal cancer risk. Clin Pharmacol Ther 75:17

    Article  Google Scholar 

  • Gill S, Sinicrope FA (2005) Colorectal cancer prevention: is an ounce of prevention worth a pound of cure? Semin Oncol 32:24–34

    Article  PubMed  CAS  Google Scholar 

  • Higgins CF (1992) ABC transporters: from microorganisms to man. Annu Rev Cell Biol 8:67–113

    Article  PubMed  CAS  Google Scholar 

  • Ho GT, Moodie FM, Satsangi J (2003) Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease. Gut 52:759–766

    Article  PubMed  CAS  Google Scholar 

  • Ho GT, Nimmo ER, Tenesa A et al (2005) Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology 128:288–296

    Article  PubMed  CAS  Google Scholar 

  • Ho GT, Soranzo N, Nimmo ER et al (2006) ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum Mol Genet 15:797–805

    Article  PubMed  CAS  Google Scholar 

  • Hoffmeyer S, Burk O, von Richter O et al (2000) Functional polymorphisms of the human multidrug resistance gene Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 97:3473–3478

    Article  PubMed  CAS  Google Scholar 

  • Johnstone RW, Ruefli AA, Smyth MJ (2000) Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem Sci 251–6

  • Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152–162

    Article  PubMed  CAS  Google Scholar 

  • Kimchi-Sarfaty C, Gribar JJ, Gottesman MM (2002) Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. Mol Pharmacol 62:1–6

    Article  PubMed  CAS  Google Scholar 

  • Korea National Statistical Office (2005) Annual report on the cause of death statistics: trends in deaths and death rates by sex from 103 causes according to The Condensed List of General Mortality 1995–2005: http://kosis.nso.go.kr/Magazine/NEW/YD/VD00010.xls

  • Kurata Y, Ieiri I, Kimura M et al (2002) Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Clin Pharmacol Ther 72:209–219

    Article  PubMed  CAS  Google Scholar 

  • Kurzawski M, Droździk M, Suchy J et al (2005) Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol 61:389–394

    Article  PubMed  CAS  Google Scholar 

  • Lacueva FJ, Calpena R, Medrano J et al (2000) Changes in P-glycoprotein expression in gastric carcinoma with respect to distant gastric mucosa may be influenced by p53. Cancer 89:21–28

    Article  PubMed  CAS  Google Scholar 

  • Lee SS, Kim SY, Kim WY et al. (2005) MDR1 genetic polymorphisms and comparison of MDR1 haplotype profiles in Korean and Vietnamese populations. Ther Drug Monit 27:531–535

    Google Scholar 

  • Mayer U, Wagenaar E, Beijnen JH et al (1996) Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein. Br J Pharmacol 119:1038–1044

    Article  PubMed  CAS  Google Scholar 

  • Mochida Y, Taguchi K, Taniguchi S et al (2003) The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice. Carcinogenesis 24:1219–1224

    Article  PubMed  CAS  Google Scholar 

  • Murray CJ, Lopez AD (1997) Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349:1269–1276

    Article  PubMed  CAS  Google Scholar 

  • Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: globocan 2000. Int J Cancer 94:153–156

    Article  PubMed  CAS  Google Scholar 

  • Pauli-Magnus C, Feiner J, Brett C et al (2003) No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects. Clin Pharmacol Ther 74:487–498

    Article  PubMed  CAS  Google Scholar 

  • Qian X, Cao S, Yang G et al (2011) Variant genotypes of MDR1 C3435T increase the risk of leukemia: evidence from 10 case–control studies. Leuk Lymphoma 53:1183–1187

    Article  Google Scholar 

  • Randolph GJ, Beaulieu S, Pope M et al (1998) A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci U S A 95:6924–6929

    Article  PubMed  CAS  Google Scholar 

  • Rao DN, Anuradha C, Vishnupriya S et al (2010) Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India. Asian Pac J Cancer Prev 11:1063–1066

    PubMed  Google Scholar 

  • Schwab M, SchaeVeler E, Marx C et al (2003) Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124:26–33

    Article  PubMed  CAS  Google Scholar 

  • Siegsmund M, Brinkmann U, Schaffeler E et al (2002) Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 13:1847–1854

    Article  PubMed  CAS  Google Scholar 

  • Sparreboom A, van Asperen J, Mayer U et al (1997) Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci U S A 94:2031–2035

    Article  PubMed  CAS  Google Scholar 

  • Sugawara I, Kataoka I, Morishita Y et al (1988) Tissue distribution of P-glycoprotein encoded by multidrug-resistance gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 48:1926–1929

    PubMed  CAS  Google Scholar 

  • Tanabe M, Ieiri I, Nagata N et al. (2001) Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 297:1137–1143

    Google Scholar 

  • Tang K, Ngoi SM, Gwee PC et al (2002) Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics 12:437–450

    Article  PubMed  CAS  Google Scholar 

  • Tanigawara Y (2000) Role of P-glycoprotein in drug disposition. Ther Drug Monit 22:137–140

    Article  PubMed  CAS  Google Scholar 

  • Thiebaut F, Tsuruo T, Hamada H et al (1987) Cellular localization of the multidrug-resistance gene product Pglycoprotein in normal human tissues. Proc Natl Acad Sci U S A 84:7735–7738

    Article  PubMed  CAS  Google Scholar 

  • Urcelay E, Mendoza JL, Martin MC et al (2006) MDR1 gene: susceptibility in Spanish Crohn’s disease and ulcerative colitis patients. Inflamm Bowel Dis 12:33–37

    Article  PubMed  Google Scholar 

  • Woodahl EL, Yang Z, Bui T et al (2004) Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein. J Pharmacol Exp Ther 310:1199–1207

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, 1 Hoegi-Dong, Dongdaemun-Gu, Seoul, 130-701, Republic of Korea

    Hyun-Ju Kim & Jae-Young Um

  2. Department of Oriental Pharmacy, College of Pharmacy, Wonkwang University, 344-2 Shinyong-dong, Iksan, Jeonbuk, 570-749, Republic of Korea

    Yun-Kyung Kim

Authors
  1. Hyun-Ju Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jae-Young Um
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yun-Kyung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jae-Young Um or Yun-Kyung Kim.

Additional information

Jae-Young Um and Yun-Kyung Kim they have equally contributed as corresponding authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, HJ., Um, JY. & Kim, YK. Association of a multidrug resistance 1 gene polymorphism and colorectal cancer in the Korean population. Orient Pharm Exp Med 13, 225–230 (2013). https://doi.org/10.1007/s13596-013-0136-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13596-013-0136-0

Keywords

Search

Navigation